Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells
Clinical trial NCT07236931 · COMPLETED
Trial details
- NCT number
- NCT07236931
- Sponsor
- Donghua Zhang
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-05-30
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.